Reattachment of the retina at 6 months · people with simple rhegmatogenous retinal detachments
Pneumatic retinopexy showed no clear difference in reattachment of the retina at 6–12 months compared with scleral buckle (low certainty).
1 finding from 1 review
RR 0.91 [0.81, 1.02]
Studies not reported
Low
Recurrence of retinal detachment at 6–12 months · people with simple rhegmatogenous retinal detachments
Pneumatic retinopexy showed no clear difference in recurrence of retinal detachment at 6–12 months compared with scleral buckle (low certainty).
1 finding from 1 review
RR 1.7 [0.97, 2.98]
Studies not reported
Low
Change in distance BCVA, between baseline and 12 months · people with simple rhegmatogenous retinal detachments
Pneumatic retinopexy showed no clear difference in mean change in BCVA at 12 months from baseline compared with scleral buckle (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Proportion of eyes with final BCVA 20/40 or better at 6 months · people with simple rhegmatogenous retinal detachments
Pneumatic retinopexy may leads to higher proportion of eyes with final BCVA 20/40 or better at 6 months compared with scleral buckle (low certainty).
1 finding from 1 review
RR 1.31 [1.04, 1.65]
Studies not reported
Low
Any operative ocular adverse event at 6–24 months · people with simple rhegmatogenous retinal detachments
Pneumatic retinopexy showed no clear difference in any operative ocular adverse event at 6–24 months compared with scleral buckle (low certainty).
1 finding from 1 review
RR 0.55 [0.28, 1.11]
Studies not reported
Low
Quality of life · people with simple rhegmatogenous retinal detachments
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · bleeding patients or at risk of severe bleeding
It is very uncertain whether fibrinogen concentrate changes mortality compared with any comparator (very low certainty).
1 finding from 1 review
Incidence of allogenic blood transfusion Proportion of participants transfused with RBC, FFP, PLT and/or cryo · bleeding patients or at risk of severe bleeding
It is very uncertain whether fibrinogen concentrate changes incidence of allogenic blood transfusion Proportion of participants… compared with any comparator (very low certainty).
1 finding from 1 review
Thrombotic episodes (arterial and venous graft occlusion, pulmonary embolus, deep venous thrombosis) Proportion with event · bleeding patients or at risk of severe bleeding
It is very uncertain whether fibrinogen concentrate changes thrombotic episodes (arterial and venous graft occlusion, pulmonary… compared with any comparator (very low certainty).
1 finding from 1 review
ICU length of stay (general intensive care patients) · bleeding patients or at risk of severe bleeding
1 finding from 1 review
Re‐operation due to persistent bleeding Events during admission · bleeding patients or at risk of severe bleeding
It is very uncertain whether fibrinogen concentrate changes re‐operation due to persistent bleeding Events during admission compared with any comparator (very low certainty).
1 finding from 1 review
Antibiotic resistance: change from baseline in P aeruginosa CFU/g of sputum at week 24 · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Antibiotic resistance: change from baseline in P aeruginosa CFU/g of sputum at week 24 · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Antibiotic resistance: change from baseline in P aeruginosa CFU/g of sputum at week 24 · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Antibiotic resistance: change from baseline in P aeruginosa CFU/g of sputum at week 24 · adults and children aged over 12 with CF and P aeruginosa
1 finding from 1 review
Antibiotic resistance: change from baseline in P aeruginosa CFU/g of sputum at week 24 · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Antibiotic resistance: frequency of tobramycin‐resistant P aeruginosa · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Summary of findings: anti‐pseudomonal antibiotics showed no clear difference in antibiotic resistance: frequency of tobramycin‐resistant P aeruginosa compared with placebo (moderate certainty).
1 finding from 1 review
Visual acuity · 5‐ to 8‐year‐old children with amblyopia
2 findings from 1 review
Change in distance BCVA in the amblyopic eye 12 months after cessation of treatment · 5‐ to 8‐year‐old children with amblyopia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant adherence to intervention · 5‐ to 8‐year‐old children with amblyopia
1 finding from 1 review